V Najfeld, N Wisch, J Mascarenhas, L Issa… - Cancer Genetics, 2011 - Elsevier A 65-year-old patient with a high hemoglobin and hematocrit was treated for 14 months with therapeutic phlebotomy when cytogenetics of bone marrow revealed 100% cells with the Ph chromosome and 45% of the Ph+ cells contained trisomy 8. Treatment with tyrosine ... Related articles - All 3 versions
JM Hagenkord, Z Gatalica, E Jonasch… - Cancer Genetics, 2011 - Elsevier Kidney and upper urinary tract cancers account for approximately 54,000 cases every year in the United States, and represent about 3.7% of adult malignancies, with more than 13,000 annual deaths. Classification of renal tumors is typically based on histomorphologic ...
[HTML] from pnas.orgI Cima, R Schiess, P Wild, M Kaelin… - Proceedings of the …, 2011 - National Acad Sciences A key barrier to the realization of personalized medicine for cancer is the identification of biomarkers. Here we describe a two-stage strategy for the discovery of serum biomarker signatures corresponding to specific cancer-causing mutations and its application to prostate cancer ( ... Cited by 3 - Related articles - All 6 versions
C Eng - JAMA: The Journal of the American Medical …, 2011 - Am Med Assoc Close inspection reveals that this is not the typical cancer genetics textbook, which would correctly focus on the high-penetrance mendelian genes associated with hereditary breast and ovarian cancer syndrome, BRCA1 and BRCA2, and with Lynch syndrome (hereditary ...
KR Blazer, DJ MacDonald, JO Culver… - Genetics in …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... All 3 versions